GLP-3RT15 10 Vial Kit

15 MG

Retatrutide is a synthetic, multi-targeted GLP receptor agonist engineered to simultaneously activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This triple receptor activation enhances satiety, optimizes glucose control, and promotes significant and sustained weight loss, offering substantial advantages over conventional single-receptor agonists.